Covance, Inc. (NYSE:CVD)

CAPS Rating: 4 out of 5

A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

Recs

0
Player Avatar dmk516 (< 20) Submitted: 11/11/2010 8:34:03 PM : Outperform Start Price: $47.13 CVD Score: -10.57

just looking at the chart

Featured Broker Partners


Advertisement